15-OR: Self-Efficacy and Mood in Youths with T1D before and after a Curriculum-Based Group Intervention

Autor: Sarah H. Gamez, Olivia Hsin, Jennifer K. Raymond, Lynda K. Fisher, Cynthia E. Munoz

Publikováno v: Diabetes. 69

Introduction: Youths with type 1 diabetes (T1D) are at significant risk for diabetes burnout and distress, as well as depressive symptoms. These social-emotional vulnerabilities have been linked with suboptimal child health outcomes. TEEN POWER® is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3ecd9d0bdb471f0b1aa9796479863cc5
https://doi.org/10.2337/db20-15-or

Targets and teamwork: Understanding differences in pediatric diabetes centers treatment outcomes

Autor: Mark R. Palmert, Soren E. Skovlund, Henk-Jan Aanstoot, Premyslawa K Jarosz-Chobot, Fergus J. Cameron, Mirjana Kocova, Harry Dorchy, Andreas Neu, Giovanni Chiari, Pål R. Njølstad, Henrik B. Mortensen, Peter G.F. Swift, Tatsuhiko Urakami, Timothy Barrett, Lynda K. Fisher, Jean-Jacques Robert, Shlomit Shalitin, Thomas Danne, Eero A. Kaprio, Jan Åman, Carine de Beaufort, Timothy Skinner, Karin Lange, Hilary Hoey, Francesco Chiarelli, Edna Roche, Cintia G Castro-Correia, Luis Castaňo, Eugen Schönle

Publikováno v: Pediatric Diabetes. 19:559-565

OBJECTIVE The reason for center differences in metabolic control of childhood diabetes is still unknown. We sought to determine to what extent the targets, expectations, and goals that diabetes care professionals have for their patients is a determin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a90675a19fcc5cd7ece27963eaed81c
https://doi.org/10.1111/pedi.12606

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial

Autor: Stephen E, Gitelman, Peter A, Gottlieb, Mark R, Rigby, Eric I, Felner, Steven M, Willi, Lynda K, Fisher, Antoinette, Moran, Michael, Gottschalk, Wayne V, Moore, Ashley, Pinckney, Lynette, Keyes-Elstein, Sudeepta, Aggarwal, Deborah, Phippard, Peter H, Sayre, Linna, Ding, Jeffrey A, Bluestone, Mario R, Ehlers, Betty, Flores

Publikováno v: Gitelman, SE; Gottlieb, PA; Rigby, MR; Felner, EI; Willi, SM; Fisher, LK; et al.(2013). Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial. The Lancet Diabetes and Endocrinology, 1(4), 306-316. doi: 10.1016/S2213-8587(13)70065-2. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/2sp5f6xx

Background: Type 1 diabetes results from T-cell-mediated destruction of β cells. Findings from preclinical studies and pilot clinical trials suggest that antithymocyte globulin (ATG) might be effective for reducing this autoimmune response. We asses

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::675987137597c23e018d0a31b475c9c7
https://doi.org/10.1016/s2213-8587(13)70065-2

Diabetes Management in Correctional Institutions

Autor: Michael Puisis, Linda B. Haas, Ronald M Shansky, Joan V Hill, Kathy Salomone, Stephanie Guerken, Joanne Dorman, Barbara Wakeen, David M. Kendall, Lynda K. Fisher, Daniel L. Lorber, R Scott Chavez

Publikováno v: Diabetes Care

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8512618f734ee5acd05ed084dedac516
http://europepmc.org/articles/PMC3537278

The selection of children and adolescents for treatment with continuous subcutaneous insulin infusion (CSII)

Autor: Lynda K. Fisher

Publikováno v: Pediatric Diabetes. 7:11-14

Continuous subcutaneous insulin infusion (CSII) was first introduced as a mode of treatment for persons with type 1 diabetes mellitus (T1DM) in the late 1970s. Since that time, there have been many reports and reviews of this modality of treatment in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ee2ef83adbb0194abdab5829fa015ed
https://doi.org/10.1111/j.1399-543x.2006.00173.x